Sekisui Chemical Co., Ltd.
Financial Summary for the Third Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
Consolidated net sales for the third quarter of the fiscal year ending March 2026 reached 959.9 billion yen (up 0.5% YoY), operating income was 72.9 billion yen (down 5.8% YoY), and net income attributable to owners of parent for the quarter was 47.8 billion yen (down 30.2% YoY).
Key Figures
- Net Sales: 959.9 billion yen (Up 0.5% Year-over-Year)
- Operating Income: 72.9 billion yen (Down 5.8% Year-over-Year)
- Net Income Attributable to Owners of Parent: 47.8 billion yen (Down 30.2% Year-over-Year)
AI要約
Overview of Performance
Consolidated net sales for the cumulative third quarter period of the fiscal year ending March 2026 reached 959.9 billion yen (up 0.5% Year-over-Year), marking a new record high. Operating income was 72.9 billion yen (down 5.8% YoY), ordinary income was 80.7 billion yen (down 6.2% YoY), and net income attributable to owners of parent for the quarter was 47.8 billion yen (down 30.2% YoY). The sluggish domestic housing market and weak global automotive production impacted results. However, solid conditions in the smartphone, semiconductor, and aircraft sectors, expanded sales of high value-added products, improved housing business composition, and growth in the renovation business contributed to the increase in net sales. On the other hand, the sluggish EV market, temporary expenses related to resin sales transactions, and impairment losses recorded in the biorefinery business pressured profits.
Segment Overview and Future Outlook
The Housing Company recorded net sales of 395.0 billion yen (up 2.4% YoY) and operating income of 26.0 billion yen (up 12.0% YoY), achieving both sales and profit growth. Expansion of sales in high-priced detached and multi-family housing, as well as increased orders in the renovation business contributed. The Environment & Life Infrastructure Company posted net sales of 172.6 billion yen (down 1.0% YoY) and operating income of 14.1 billion yen (down 5.9% YoY), resulting in a decline in both sales and profits, but focused on expanding sales of core products and overseas sales growth. The High-Performance Plastics Company reported net sales of 337.7 billion yen (up 1.4% YoY) and operating income of 44.0 billion yen (down 3.1% YoY), reflecting sales growth but profit decline. The Medical Business recorded net sales of 68.0 billion yen (down 6.8% YoY) and operating income of 7.3 billion yen (down 21.5% YoY), showing decreases in sales and profit. The full-year earnings forecast was revised to net sales of 1.3279 trillion yen (up 0.4% from previous forecast), operating income of 110 billion yen (unchanged), and net income of 72 billion yen (unchanged), with the annual dividend forecast maintained at 80 yen.